This provider's $9.2M in total Medicare payments ranks in the 90th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 3222% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 770% in 2018
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $610.24 | $160.52 | 3.80x | $449.72 | $43.5K | 271 | 166 |
| 2018 | $610.24 | $241.98 | 2.52x | $368.26 | $378.5K | 1.6K | 650 |
| 2019 | $506.35 | $196.74 | 2.57x | $309.61 | $1.3M | 5.4K | 2.4K |
| 2020 | $359.96 | $144.73 | 2.49x | $215.23 | $1.2M | 8.4K | 5.8K |
| 2021 | $229.90 | $87.71 | 2.62x | $142.19 | $2.7M | 42.8K | 31.1K |
| 2022 | $162.75 | $69.35 | 2.35x | $93.40 | $2.0M | 21.9K | 15.5K |
| 2023 | $95.31 | $37.90 | 2.51x | $57.41 | $1.4M | 9.6K | 5.5K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 20.8K | $5.0M | $242.33 | 2.32x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 29.1K | $2.3M | $78.95 | 3.17x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.2K | $625.5K | $196.62 | 2.11x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 20.5K | $511.2K | $24.93 | 1.00x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 2.5K | $381.5K | $154.94 | 2.03x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 10.0K | $234.7K | $23.44 | 1.28x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 414 | $46.4K | $112.14 | 1.43x |
| 86409 | Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19) | 138 | $11.0K | $79.46 | 1.89x |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 167 | $8.4K | $50.28 | 4.97x |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | 83 | $7.8K | $93.88 | 2.66x |
| 87804 | Detection test by immunoassay for influenza virus | 460 | $7.5K | $16.36 | 7.64x |
| 86408 | Screening test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) neutralizing antibody | 165 | $6.9K | $42.06 | 2.38x |
| 80053 | Blood test, comprehensive group of blood chemicals | 432 | $4.5K | $10.35 | 3.57x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 553 | $4.2K | $7.61 | 3.57x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 252 | $3.3K | $13.12 | 3.57x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 185 | $3.0K | $16.46 | 3.57x |
| 87807 | Detection test by immunoassay for respiratory syncytial virus (rsv) | 215 | $2.8K | $12.93 | 7.73x |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | 28 | $1.9K | $68.80 | 3.57x |
| 82306 | Vitamin d-3 level | 61 | $1.8K | $29.01 | 3.57x |
| 83036 | Hemoglobin a1c level | 111 | $1.1K | $9.52 | 3.57x |
This provider submits charges 2.41 times higher than what Medicare actually pays.
A markup ratio of 2.41x means for every $100 Medicare pays, this provider initially charges $241. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in MI for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Vpa Pc | Troy, MI | $119.3M | ✓ Clear |
| Biotech Clinical Laboratories Inc | Novi, MI | $89.7M | ✓ Clear |
| Orchard Laboratories Corp | West Bloomfield, MI | $78.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data